BOT has three successful Phase 1b trials in ance, dermatitis and psoriasis, with the four antimicrobial product most likely bypassing Phase 1b in my opinion due to the safety profile of the other three. Phase 2 results for acne are due in September while dermatitis is due in December.
Do not get me wrong though, I find the IHL story very compelling and have taken a position.
BOT has three successful Phase 1b trials in ance, dermatitis and...
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)